Italy Menopause Market Size & Outlook, 2022-2030
Italy menopause market, 2018-2030 (US$M)
Related Markets
Italy menopause market highlights
- The Italy menopause market generated a revenue of USD 491.6 million in 2022 and is expected to reach USD 733.5 million by 2030.
- The Italy market is expected to grow at a CAGR of 5.1% from 2023 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
- Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2022 | USD 491.6 million |
| Market revenue in 2030 | USD 733.5 million |
| Growth rate | 5.1% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Dietary Supplements |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, Italy accounted for 3.0% of the global menopause market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany menopause market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 452.9 million by 2030.
Dietary supplements was the largest segment with a revenue share of 94.75% in 2022. Horizon Databook has segmented the Italy menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The number of women opting for Hormone Replacement Therapy (HRT) is low and the adoption of food supplements is increasing in the country. According to a study published by Minerva Medica, in December 2015, only 6%–8% of women opted for HRT for insomnia and hot flashes. Moreover, studies are being conducted to check the effects of supplements in menopause.
In April 2016, Natural Product Communications published a study that mentioned soy germ might help improve menopausal symptoms, especially the occurrence of insomnia, sexual dysfunction, and hot flashes. The low adoption of HRT for menopause, along with studies supporting dietary supplements for easing menopausal symptoms, is expected to positively impact the market in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy menopause market size, by treatment, 2018-2030 (US$M)
Italy Menopause Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
